Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

First-In-Human, Dose Escalation, Phase I Study Of An Antibody-Based Immunotherapy In Patients With Solid Tumor (Kopie)

BiconY Therapeutics GmbH Germany has Released a tender for First-In-Human, Dose Escalation, Phase I Study Of An Antibody-Based Immunotherapy In Patients With Solid Tumor (Kopie) in Healthcare Equipment and Services. The tender was released on Nov 19, 2024.

Country - Germany

Summary - First-In-Human, Dose Escalation, Phase I Study Of An Antibody-Based Immunotherapy In Patients With Solid Tumor (Kopie)

Deadline - Dec 04, 2024

GT reference number - 97813179

Product classification - Services provided by medical laboratories

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 97813179

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial).local title:: First-in-human, dose escalation, phase I study of an antibody-based imm unotherapy in patients with solid tumor (Kopie)Contract Duration: : 4 YEARContract Type: : Servicelocal description: : Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial). dispatch_date: 2024-11-15 00:00:00 lot_details: 1: First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (Kopie)

Gt Ref Id - 97813179

Deadline - Dec 04, 2024

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database